- Home
- GNSS vs GNTA Comparison
GNSS vs GNTA Comparison
Compare GNSS & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- GNTA
- Stock Information
- Founded
- GNSS 1992
- GNTA 2014
- Country
- GNSS United States
- GNTA Italy
- Employees
- GNSS N/A
- GNTA N/A
- Industry
- GNSS Consumer Electronics/Appliances
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GNSS Consumer Staples
- GNTA Health Care
- Exchange
- GNSS Nasdaq
- GNTA Nasdaq
- Market Cap
- GNSS 78.1M
- GNTA 81.2M
- IPO Year
- GNSS N/A
- GNTA 2021
- Fundamental
- Price
- GNSS $1.96
- GNTA $3.91
- Analyst Decision
- GNSS Strong Buy
- GNTA Strong Buy
- Analyst Count
- GNSS 3
- GNTA 1
- Target Price
- GNSS $5.33
- GNTA $25.00
- AVG Volume (30 Days)
- GNSS 132.0K
- GNTA 28.8K
- Earning Date
- GNSS 08-05-2025
- GNTA 01-01-0001
- Dividend Yield
- GNSS N/A
- GNTA N/A
- EPS Growth
- GNSS N/A
- GNTA N/A
- EPS
- GNSS N/A
- GNTA N/A
- Revenue
- GNSS $27,780,000.00
- GNTA N/A
- Revenue This Year
- GNSS $93.74
- GNTA N/A
- Revenue Next Year
- GNSS $77.74
- GNTA N/A
- P/E Ratio
- GNSS N/A
- GNTA N/A
- Revenue Growth
- GNSS N/A
- GNTA N/A
- 52 Week Low
- GNSS $1.46
- GNTA $2.74
- 52 Week High
- GNSS $4.04
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- GNSS 70.78
- GNTA 55.67
- Support Level
- GNSS $1.48
- GNTA $3.69
- Resistance Level
- GNSS $1.85
- GNTA $3.94
- Average True Range (ATR)
- GNSS 0.10
- GNTA 0.29
- MACD
- GNSS 0.05
- GNTA 0.10
- Stochastic Oscillator
- GNSS 98.11
- GNTA 92.06
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.